Skip to main content
. 2013 Jun 4;6:145–149. doi: 10.2147/CCID.44853

Table 1.

Underlying hematological diagnoses

Hematological condition Number of cases (%)
Myeloid neoplasms
 Acute myeloid leukemia 19 (32.76%)
 Acute biphenotypic leukemia 1 (1.72%)
 Myeloproliferative disease 6 (10.35%)
 Myelodysplastic disease 3 (5.17%)
Lymphoid neoplasms
 B-cell neoplasms 12 (20.69%)
 T-cell and NK-cell neoplasms 4 (6.90%)
 Acute lymphoblastic leukemia 4 (6.90%)
Hodgkin lymphoma 1 (1.72%)
Lymphoma (unclassified) 1 (1.72%)
Post-transplant lymphoproliferative disorder (PTLD) 1 (1.72%)
Hypereosinophilic syndrome 1 (1.72%)
Amegakaryocytic thrombocytopenia 1 (1.72%)
Medullary glioma 1 (1.72%)
Others (anemia, thrombocytopenia, infectious mononucleosis) 3 (5.17%)
Total 58 (100%)

Abbreviation: NK, natural killer.